Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Antidepressive agents of recent generation]

T Bougerol1

  • 1Service de psychiatrie d'adultes, CHU Sainte-Marguerite, Marseille.

La Revue Du Praticien
|November 1, 1994
PubMed
Summary

New generation antidepressants offer improved safety and efficacy for depression treatment. Selective serotonin reuptake inhibitors represent a major advance, making them a preferred choice for uncomplicated depressive disorders.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Early intervention in bipolar affective disorders: Why, when and how].

L'Encephale·2021
Same author

Evolution and characteristics of the use of valproate in women of childbearing age with bipolar disorder: Results from the FACE-BD cohort.

Journal of affective disorders·2020
Same author

Minimum clinically important differences for the Functioning Assessment Short Test and a battery of neuropsychological tests in bipolar disorders: results from the FACE-BD cohort.

Epidemiology and psychiatric sciences·2020
Same author

Adherence to treatment guidelines in clinical practice for using electroconvulsive therapy in major depressive episode.

Journal of affective disorders·2020
Same author

Clinical guidelines for the management of treatment-resistant depression: French recommendations from experts, the French Association for Biological Psychiatry and Neuropsychopharmacology and the fondation FondaMental.

BMC psychiatry·2019
Same author

Clinical guidelines for the management of depression with specific comorbid psychiatric conditions French recommendations from experts (the French Association for Biological Psychiatry and Neuropsychopharmacology and the fondation FondaMental).

BMC psychiatry·2019

Area of Science:

  • Psychopharmacology
  • Neuroscience

Context:

  • Recent advancements in psychopharmacology have yielded novel antidepressant compounds.
  • These new agents include modified classical antidepressants and entirely new pharmacological classes.

Purpose:

  • To review the characteristics and therapeutic potential of new generation antidepressants.
  • To highlight the advantages of these newer agents over traditional antidepressants.

Summary:

  • Newer antidepressants, including novel tricyclics and MAOIs, possess fewer contraindications (e.g., reduced anticholinergic effects, no dietary restrictions).
  • Non-tricyclic, non-MAOI antidepressants, particularly selective serotonin reuptake inhibitors (SSRIs), demonstrate favorable safety and tolerability profiles.
  • These compounds show efficacy beyond depression, impacting anxiety and obsessive-compulsive disorders.

Impact:

  • New generation antidepressants are recommended as first-line treatment for uncomplicated depressive disorders.
  • The improved safety and broader efficacy of these agents signify a significant therapeutic progress.

Related Experiment Videos